We are live on ! Find out more
AGN

Allergan Inc
AGN

Delisted

AGN was delisted on the 16th of March, 2015.

13 hedge funds and large institutions have $14M invested in Allergan Inc in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less capital invested

Capital invested by funds: $16.8M → $14M (-$2.83M)

24% less funds holding

Funds holding: 1713 (-4)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
13
Holders Change
-4
Holders Change %
-23.53%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
4
Closed
4
Calls
Puts
Net Calls
Net Calls Change

AGN Hedge Fund Activity: Q2 2017 in Review

13 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q2 2017, worth a combined $14M — down 17% from $16.8M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of AGN and 0 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 3 added.

The largest buyer was Dowling & Yahnke, adding an estimated $75.2K. The largest seller was Henry H. Armstrong Associates, exiting entirely with an estimated $882K sold.

  • 13 institutional investors held Allergan Inc (AGN) as of Q2 2017, down from 17 in Q1 2017.
  • Funds reported $14M of Allergan Inc stock for Q2 2017, down 17% quarter-over-quarter.
  • 0 funds opened new Allergan Inc positions in Q2 2017 and 4 closed out, a net change of -4 holders.
  • The largest Allergan Inc buyer in Q2 2017 was Dowling & Yahnke, an estimated $75.2K added.
  • The largest Allergan Inc seller in Q2 2017 was Henry H. Armstrong Associates, an estimated $882K sold.

Based on aggregated 13F filings for Q2 2017.